Interestingly, a recent study reported that ablating STAT3 in CD8+ T cells prior to the CD8+ T cell transfer allows for efficient CD8+ T cell tumor infiltration and robust proliferation, resulting in increased tumor antigen-specific T cell activity and tumor growth inhibition [58]. This evidence concerns the gene CD8A and neoplasm.